Publication | Closed Access

Aspirin plus extended-release dipyridamole or clopidogrel compared with aspirin monotherapy for the prevention of recurrent ischemic stroke: A cost-effectiveness analysis

Cost-effectiveness AnalysisCerebrovascular DiseasePharmacotherapyThrombosisNeurologyPublic HealthPlatelet AntagonistAtherosclerosisIschemic SyndromeAspirin MonotherapyMedicineRecurrent Ischemic StrokeOutcomes ResearchCerebral Blood FlowPharmacologyIschemic StrokeCardiovascular DiseaseStrokeAnticoagulant